- Report
- May 2024
- 138 Pages
Global
From €6230EUR$6,499USD£5,206GBP
- Report
- June 2024
- 200 Pages
Global
From €7621EUR$7,950USD£6,368GBP
- Report
- March 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- October 2024
- 180 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- October 2024
- 195 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- September 2024
- 80 Pages
Global
From €5704EUR$5,950USD£4,766GBP
- Report
- April 2025
- 187 Pages
Global
From €4745EUR$4,950USD£3,965GBP
- Report
- February 2025
- 150 Pages
Global
From €4650EUR$4,850USD£3,885GBP
- Report
- May 2024
- 131 Pages
Global
From €6230EUR$6,499USD£5,206GBP
- Clinical Trials
- December 2024
- 60 Pages
Global
From €1198EUR$1,250USD£1,001GBP
- Report
- September 2024
- 95 Pages
Global
From €7621EUR$7,950USD£6,368GBP
- Report
- October 2024
- 250 Pages
Global
From €4744EUR$4,949USD£3,964GBP
- Report
- October 2024
- 200 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Report
- January 2022
- 196 Pages
Global
From €7190EUR$7,500USD£6,008GBP
- Report
- January 2022
- 60 Pages
Global
From €3787EUR$3,950USD£3,164GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1917EUR$2,000USD£1,602GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1917EUR$2,000USD£1,602GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1917EUR$2,000USD£1,602GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1198EUR$1,250USD£1,001GBP
- Report
- January 2022
- 120 Pages
Global
From €4554EUR$4,750USD£3,805GBP

Iron overload is a condition in which the body accumulates too much iron, which can lead to organ damage. It is a common complication of certain blood disorders, such as thalassemia and sickle cell anemia, and can also be caused by certain medications, such as those used to treat Central Nervous System (CNS) diseases. Iron overload can cause a variety of symptoms, including fatigue, joint pain, and abdominal pain. Treatment typically involves chelation therapy, which involves the use of drugs to remove excess iron from the body.
The Iron Overload market is a subset of the CNS drugs market, and is focused on the development of drugs to treat iron overload. These drugs are typically chelators, which bind to iron and remove it from the body. The market is highly competitive, with a number of companies developing new drugs to treat iron overload.
Some companies in the Iron Overload market include Sanofi, Pfizer, Novartis, and GlaxoSmithKline. Show Less Read more